HIV risk behaviour, viraemia, and transmission across HIV cascade stages including low-level viremia: Analysis of 14 cross-sectional population-based HIV Impact Assessment surveys in sub-Saharan Africa.

Autor: Edun O; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom., Okell L; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom., Chun H; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Bissek AZ; Division of Health Operations Research, Ministry of Public Health, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé, Yaoundé, Cameroon., Ndongmo CB; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Yaoundé, Cameroon., Shang JD; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Yaoundé, Cameroon., Brou H; ICAP, Columbia University, Abidjan, Côte d'Ivoire., Ehui E; National AIDS Control Programme, Ministry of Health, Public Hygiene and Universal Health Coverage, Abidjan, Côte d'Ivoire., Ekra AK; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Abidjan, Côte d'Ivoire., Nuwagaba-Biribonwoha H; ICAP at Columbia University and Department of Epidemiology, Mailman School of Public Health, Mbabane, Eswatini., Dlamini SS; Ministry of Health, Mbabane, Eswatini., Ginindza C; Central Statistical Office, Mbabane, Eswatini., Eshetu F; U.S. Centers for Disease Control and Prevention Division of Global HIV/TB, Center for Global Health, Addis Ababa, Ethiopia., Misganie YG; Ethiopian Public Health Institute, HIV/AIDS and TB Research Directorate, Addis Ababa, Ethiopia.; School of Medicine, Zhejiang University, Hangzhou, China., Desta SL; ICAP in Ethiopia, Mailman School of Public Health, Columbia University, Addis Ababa, Ethiopia., Achia TNO; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Nairobi, Kenya., Aoko A; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Nairobi, Kenya., Jonnalagadda S; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Nairobi, Kenya., Wafula R; National AIDS and STI Control Programme, Ministry of Health, Nairobi, Kenya., Asiimwe FM; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Maseru, Lesotho., Lecher S; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Maseru, Lesotho., Nkanaunena K; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Lilongwe, Malawi., Nyangulu MK; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Lilongwe, Malawi., Nyirenda R; Department of HIV/AIDS, Ministry of Health, Lilongwe, Malawi., Beukes A; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Windhoek, Namibia., Klemens JO; Namibia Institute of Pathology Limited, Windhoek, Namibia., Taffa N; Ministry of Health and Social Services, Windhoek, Namibia., Abutu AA; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Abuja, Nigeria., Alagi M; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Abuja, Nigeria., Charurat ME; Center for International Health, Education, and Biosecurity (Ciheb), University of Maryland School of Medicine, Baltimore, Maryland, United States of America.; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Dalhatu I; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Abuja, Nigeria., Aliyu G; National Agency for the Control of AIDS, Abuja, Nigeria., Kamanzi C; ICAP, Columbia University, Kigali, Rwanda., Nyagatare C; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Kigali, Rwanda., Rwibasira GN; HIV, STIs, Viral Hepatitis & OVDC Department, Rwanda Biomedical Center, Kigali, Rwanda., Jalloh MF; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Dar es Salaam, Tanzania., Maokola WM; National AIDS Control Programme, Tanzania Ministry of Health, Dar es Salaam, Tanzania., Mgomella GS; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Dar es Salaam, Tanzania., Kirungi WL; Ministry of Health, AIDS Control Programme, Kampala, Uganda., Mwangi C; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Kampala, Uganda., Nel JA; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Kampala, Uganda., Minchella PA; U.S. Centers for Disease Control and Prevention Division of Global HIV/TB, Center for Global Health, Lusaka, Zambia., Gonese G; Zimbabwe Technical Assistance, Training and Education Center for Health (Zim-TTECH), Harare, Zimbabwe., Nasr MA; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Harare, Zimbabwe.; Public Health Institute, Global Health Fellowship Program, United States of America., Bodika S; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Mungai E; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America.; eTeam, Somerset, New Jersey, United States of America., Patel HK; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Sleeman K; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Milligan K; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America.; Peraton, Herndon, Virginia, United States of America., Dirlikov E; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Voetsch AC; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Shiraishi RW; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Imai-Eaton JW; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.; Department of Epidemiology, Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2024 Apr 04; Vol. 4 (4), pp. e0003030. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).